News
High-selective beta-adrenergic blocking agent for arterial hypertension and ischemic heart disease treatment
30 MayA new medical product for treatment of heart-vascular system diseases named Bisoprolol VIVA PHARM in the form of a film-coated tablets No30 with dosage units of 2.5 mg, 5mg, and 10 mg was registered by the order of a Chairman of the Control over medical and pharmaceutical activity Committee of the Ministry of health and social development of the Republic of Kazakhstan. Registration ID numbers are РК-ЛС-5№022196, РК-ЛС-5№022197 and РК-ЛС-5№022198 correspondingly to dosage units. Bisoprolol is included into the WHO Model List of Essential Medicines, which are curtail for basic healthcare system. At the present time Bisoprolol is produced by the modern National manufacturer VIVA PHARM LLC.
